跳至主要内容
临床试验/NL-OMON38261
NL-OMON38261已完成不适用

Early Surgery versus optimal Current step-up prActice for chronic PancrEatitis: ESCAPE - ESCAPE

Academisch Medisch Centrum0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Age * 18 years
  • 2. Confirmed chronic pancreatitis: according to the following criteria (adapted from the M-ANNHEIM diagnostic criteria):
  • * typical clinical history of chronic pancreatitis (i.e. recurrent pancreatitis or abdominal pain), and:
  • * one or more of the following additional criteria for the diagnosis of chronic pancreatitis:
  • a. Pancreatic calcifications
  • b. Moderate or marked ductal lesions (according to the Cambridge classification) on magnetic resonance cholangiopancreatography (MRCP), computed tomography (CT) or endoscopic ultrasounds (EUS) imaging
  • c. Marked and persistent exocrine insufficiency (defined as: a. pancreatic steatorrhea clearly relieved by enzyme supplementation, and/or b. fecal elastase levels of * 200 micro gram/gram)
  • 3. Dilated pancreatic duct: dilated pancreatic duct of * 5 mm (established by MRCP, CT or EUS), with or without enlargement of the pancreatic head
  • 4. Presence of moderate, non-debilitating pain. This will be defined as chronic or recurrent abdominal pain sufficiently relieved with non-opioid analgesics;Patients will be eligible for randomization to one of the trial arms when the randomization criteria are met:
  • * In patients with chronic abdominal pain related to chronic pancreatitis: a need to upgrade pain medication from non-opioids to opioid analgesics (opioids needed at least 3 days per week) and persistently needed for at least 2 weeks in a row
  • * In patients with recurrent flare ups of chronic pancreatitis (including episodes of acute on chronic pancreatitis) and pain-free intervals that:
  • - have occurred at least 3 times during one year (i.e. 12 months);
  • - during at least 7 consecutive days;
  • - necessitate opioid use during flare up;
  • - impairs the patient in daily activities.
  • * Informed consent for randomization

排除标准

  • * History of prolonged need of opioids: history for need for strong opioids for CP for a total period over 2 months or a history for need for weak opioids for CP for a total period of 6 months in the last 2 years
  • * Previous pancreatic surgery
  • * Previous endoscopic dilatation or stenting of the pancreatic duct. Patients with previous endoscopic intervention for biliary obstruction, without intervention involving the pancreatic duct, will be eligible for the trial.
  • * Episode of biliary obstruction in the last 2 months (defined as jaundice or bilirubine levels * 25 micromol / L) or the presence of a stent in the common bile duct (CBD).
  • * Proven autoimmune pancreatitis (including elevated levels of gamma-globulins (IgG))
  • * Stones and strictures exclusively located in the tail of the pancreas (defined as to the left of the left border of the vertebra) with relatively normal pancreatic head and corpus.
  • * Fully impacted stones casting the entire main pancreatic duct (from head to tail) and side branches.
  • * Suspected or established pancreatic malignancies
  • * Life expectancy of < 1 year for any reason
  • * Presence of duodenal obstruction necessitating surgery, as judged by the expert panel
  • * Presence of a pseudocyst larger than 6 cm necessitating intervention, as judged by the expert panel
  • * Contra-indications for surgery, always evaluated by the expert panel (e.g. American Society of Anesthesiology class IV, severe portal hypertension due to occluded portal vein)
  • * Pregnancy

研究者

相似试验